Close

Analyst Ratings for Arbutus Biopharma (ABUS)

ABUS Rating Summary

ABUS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ABUS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $6.50 (+124.1%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/2/2022 Jefferies Dennis Ding Upgrade Buy
(Hold)
5.00
(4.00)
2.81
(2.90)
3.2% Details
12/17/2020 H.C. Wainwright
» Updated 11/10/2022
Ed Arce New Coverage Buy
(N/A)
6.00
(7.50)
4.41
(2.90)
-34.24% Details
Like ABUS Ratings? Also take a look at VACC, MRNA, ROIV, OGE

ABUS Ratings News